Gamma Medica, Inc.

Gamma Medica, Inc. is a womens health company focused on overcoming the critical shortcomings of mammography and other screening modalities in the early detection of breast cancer. The companys LumaGEM MBI system is the first commercially available, FDA-cleared, fully solid-state digital imaging system utilizing dual-head Digital Direct Conversion Gamma Imaging (DDCGI) technology for molecular breast imaging. With over 90 percent sensitivity and specificity, LumaGEM MBI has been shown to significantly improve cancer detection in women with dense breast tissue with fewer false positives relative to anatomical imaging technologies, such as MRI and whole breast ultrasound. For more information visit www.gammamedica.com....

Molecular breast imaging;molecular diagnostics;breast imaging

Gamma medica, inc.'s revenue is 11m - 100m

Gamma medica, inc. has 11 - 50 employees.